Education
About Us
Working with TipRanks
Follow Us
Beijing Tong Ren Tang Chinese Medicine Co (HK:3613)
:3613
RESEARCH TOOLSreports
Total Valuation
Beijing Tong Ren Tang Chinese Medicine Co has a market cap or net worth of HK$7.56B. The enterprise value is HK$5.59B.
Market CapHK$7.56B
Enterprise ValueHK$5.59B
Share Statistics
Beijing Tong Ren Tang Chinese Medicine Co has 837,100,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding837,100,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Beijing Tong Ren Tang Chinese Medicine Co’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 11.06%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)11.06%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee2.06M
Profits Per Employee805.34K
Employee Count782
Asset Turnover0.35
Inventory Turnover0.34
Valuation Ratios
The current PE Ratio of Beijing Tong Ren Tang Chinese Medicine Co is 14.7. Beijing Tong Ren Tang Chinese Medicine Co’s PEG ratio is ―.
PE Ratio14.7
PS Ratio―
PB Ratio―
Price to Fair Value1.80
Price to FCF―
Price to Operating Cash Flow-24.90
PEG Ratio―
Income Statement
In the last 12 months, Beijing Tong Ren Tang Chinese Medicine Co had revenue of 1.61B and earned 500.28M in profits. Earnings per share was 0.60.
Revenue1.61B
Gross Profit1.07B
Operating Income576.92M
Pretax Income629.77M
Net Income500.28M
EBITDA722.32M
Earnings Per Share (EPS)0.60
Cash Flow
In the last 12 months, operating cash flow was -303.86M and capital expenditures -11.22M, giving a free cash flow of -315.07M billion.
Operating Cash Flow-303.86M
Free Cash Flow-315.07M
Free Cash Flow per Share-0.38
Dividends & Yields
Beijing Tong Ren Tang Chinese Medicine Co pays an annual dividend of HK$0.35, resulting in a dividend yield of 3.98%
Dividend Per ShareHK$0.35
Dividend Yield3.98%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.78
52-Week Price Change27.24%
50-Day Moving Average9.17
200-Day Moving Average8.37
Relative Strength Index (RSI)46.05
Average Volume (3m)1.32M
Important Dates
Beijing Tong Ren Tang Chinese Medicine Co upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateAug 22, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend DateJun 05, 2025
Financial Position
Beijing Tong Ren Tang Chinese Medicine Co as a current ratio of 16.85, with Debt / Equity ratio of 3.03%
Current Ratio16.85
Quick Ratio10.10
Debt to Market Cap<0.01
Net Debt to EBITDA-2.28
Interest Coverage Ratio89.02
Taxes
In the past 12 months, Beijing Tong Ren Tang Chinese Medicine Co has paid 100.61M in taxes.
Income Tax100.61M
Effective Tax Rate0.16
Enterprise Valuation
Beijing Tong Ren Tang Chinese Medicine Co EV to EBITDA ratio is 7.89, with an EV/FCF ratio of -21.89.
EV to Sales3.54
EV to EBITDA7.89
EV to Free Cash Flow-21.89
EV to Operating Cash Flow-26.24
Balance Sheet
Beijing Tong Ren Tang Chinese Medicine Co has HK$1.83B in cash and marketable securities with HK$123.42M in debt, giving a net cash position of -HK$1.71B billion.
Cash & Marketable SecuritiesHK$1.83B
Total DebtHK$123.42M
Net Cash-HK$1.71B
Net Cash Per Share-HK$2.04
Tangible Book Value Per ShareHK$4.99
Margins
Gross margin is 66.10%, with operating margin of 35.80%, and net profit margin of 31.04%.
Gross Margin66.10%
Operating Margin35.80%
Pretax Margin39.08%
Net Profit Margin31.04%
EBITDA Margin44.82%
EBIT Margin39.48%
Analyst Forecast
The average price target for Beijing Tong Ren Tang Chinese Medicine Co is HK$10.53, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$10.53
Price Target Upside16.60% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast24.13%
EPS Growth Forecast4.29%